GB0907516D0 - Assay - Google Patents

Assay

Info

Publication number
GB0907516D0
GB0907516D0 GBGB0907516.9A GB0907516A GB0907516D0 GB 0907516 D0 GB0907516 D0 GB 0907516D0 GB 0907516 A GB0907516 A GB 0907516A GB 0907516 D0 GB0907516 D0 GB 0907516D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0907516.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Priority to GBGB0907516.9A priority Critical patent/GB0907516D0/en
Publication of GB0907516D0 publication Critical patent/GB0907516D0/en
Priority to EP10717207A priority patent/EP2425256A1/en
Priority to PCT/GB2010/000874 priority patent/WO2010125358A1/en
Priority to JP2012507815A priority patent/JP2012525576A/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2878—Muscular dystrophy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2878—Muscular dystrophy
    • G01N2800/2885—Duchenne dystrophy
GBGB0907516.9A 2009-04-30 2009-04-30 Assay Ceased GB0907516D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0907516.9A GB0907516D0 (en) 2009-04-30 2009-04-30 Assay
EP10717207A EP2425256A1 (en) 2009-04-30 2010-04-30 Method for diagnosing and treating muscular dystrophy
PCT/GB2010/000874 WO2010125358A1 (en) 2009-04-30 2010-04-30 Method for diagnosing and treating muscular dystrophy
JP2012507815A JP2012525576A (en) 2009-04-30 2010-04-30 Method for diagnosing and treating muscular dystrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0907516.9A GB0907516D0 (en) 2009-04-30 2009-04-30 Assay

Publications (1)

Publication Number Publication Date
GB0907516D0 true GB0907516D0 (en) 2009-06-10

Family

ID=40792102

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0907516.9A Ceased GB0907516D0 (en) 2009-04-30 2009-04-30 Assay

Country Status (4)

Country Link
EP (1) EP2425256A1 (en)
JP (1) JP2012525576A (en)
GB (1) GB0907516D0 (en)
WO (1) WO2010125358A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012092299A1 (en) * 2010-12-27 2012-07-05 Brown University Therapeutic and diagnostic methods involving biglycan and utrophin
CN103074426B (en) * 2013-01-05 2014-03-26 河南农业大学 Fast detection method for chicken Pax7 gene 31 bp indel polymorphism and application thereof
JP6799863B2 (en) * 2015-12-01 2020-12-16 学校法人 川崎学園 Diagnostic agent for heart or muscle disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308752A (en) * 1990-05-23 1994-05-03 Univ. Of Iowa Research Foundation Diagnosis of autosomal muscular dystrophy
AU2208097A (en) * 1996-03-08 1997-09-22 Regents Of The University Of California, The Muscular dystrophy, stroke, and neurodegenerative disease diagnosis and treatment
US7642248B2 (en) * 1999-11-05 2010-01-05 Roche Madison Inc Devices and processes for distribution of genetic material to mammalian limb
WO2009031842A1 (en) * 2007-09-04 2009-03-12 Korea University Industrial & Academic Collaborative Foundation Use of trim72 as a target for muscle and heart enhancer

Also Published As

Publication number Publication date
JP2012525576A (en) 2012-10-22
WO2010125358A1 (en) 2010-11-04
EP2425256A1 (en) 2012-03-07

Similar Documents

Publication Publication Date Title
EP2536818A4 (en) Immobilised-bead immunomultiplex assay
GB0903469D0 (en) Assay
GB0914826D0 (en) Assay methods
GB0921447D0 (en) Assay
GB0918712D0 (en) An assay
GB0908589D0 (en) Assay method
GB0904639D0 (en) Assay
GB0902565D0 (en) Assay
GB201004306D0 (en) Assay
GB0909130D0 (en) Assay device
GB0811567D0 (en) Assay
GB0807534D0 (en) Assay
GB0803850D0 (en) Assay
GB201002382D0 (en) Assay
GB0811858D0 (en) Assay
GB0809262D0 (en) Assay
GB0921873D0 (en) Assay
GB0907516D0 (en) Assay
GB0822261D0 (en) Assay
GB0822260D0 (en) Assay
GB0821624D0 (en) Assay
GB0814591D0 (en) Assay
GB0913773D0 (en) Assay
GB0822010D0 (en) Assay
GB0902493D0 (en) Assay method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)